NCT05514132 2026-03-09A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid TumoursAstraZenecaPhase 1 Active not recruiting14 enrolled
NCT03421353 2024-08-21AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerAstraZenecaPhase 1 Completed76 enrolled